As a matter of fact, we found some studies showed MCL-1 expression elevated after Imatinib compared with control group in CML patients, which was linked to the drug resistance and individual difference [44]. Here, MCL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.